Bacteroides intermedius (Holdeman and Moore) Johnson and Holdeman
Strain Designations
VPI 8944 [Lambe 729-74, NCTC 9336]
Application
Characterization
Isolation
Vincent's gingivitis, England
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Preceptrol®
no
Type Strain
yes
Comments
Subgroup 8944
Fibrinogen binding
Group B
Medium
ATCC® Medium 2722: Supplemented Tryptic Soy Broth/Agar
ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
Johnson JL, Holdeman LV. Bacteroides intermedius comb. nov. and descriptions of Bacteroides corporis sp. nov. and Bacteroides levii sp. nov.. Int. J. Syst. Bacteriol. 33: 15-25, 1983.
Lantz MS, et al. Bacteroides intermedius binds fibrinogen. J. Bacteriol. 163: 623-628, 1985. PubMed: 2991200
Nakazawa F, et al. Serological studies of oral Bacteroides intermedius. Infect. Immun. 56: 1647-1651, 1988. PubMed: 3131249
Shah HN, Gharbia SE. Biochemical and chemical studies on strains designated Prevotella intermedia and proposal of a new pigmented species, Prevotella nigrescens sp. nov.. Int. J. Syst. Bacteriol. 42: 542-546, 1992. PubMed: 1390107
